Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn https://ft.trib.al/vLjWUb7
Financial Times@FT·23mJohnson & Johnson looking to buy eye disease biotech for up to $3.4bn ft.trib.al/vLjWUb7